Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Blocking Prostaglandin D₂ may help treat hair loss.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

A new topical method using peptides boosts hair growth effectively with less finasteride and fewer side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

Tadalafil and Finasteride may help treat aggressive melanoma.

A new compound that could treat various androgen-related conditions was created and analyzed.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.